Angiovist 370: effectiveness, side effects, alternatives
Summary:
Angiovist 370: diatrizoate meglumine; diatrizoate sodium
The information eHealthMe analyzes includes:
- Effectiveness of Angiovist 370- Alternative drugs to Angiovist 370
- Angiovist 370 side effects and drug interactions
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
Do you take Angiovist 370?
- You can start a phase IV clinical trial to monitor Angiovist 370 safety and effectiveness.Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
How we gather our data?
Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference. Browse all drugs on eHealthMe.
Recent studies on eHealthMe:
- Korlym and Furosemide drug interaction - 7 seconds ago
- Keppra and Product Taste Abnormal - 14 seconds ago
- Aspirin and Optic Nerve Neoplasm - 24 seconds ago
- Cubicin and Meloxicam drug interaction - 53 seconds ago
- Glipizide vs. Regular Insulin - a minute ago
- Invokana vs. Lisinopril - a minute ago
- Gastric Varices and Rashes - a minute ago
- Calcium and Dark Circles Under Eyes - a minute ago
- Alendronic Acid and Iridocyclitis - a minute ago
- Latuda and Balance Disorder - a minute ago